Complete Plasmodium falciparum liver stage development in liver-chimeric mice

Journal of Clinical Investigation

Volumn 122, Issue 10, 2012, Pages 3618-3628

  Vaughan, Ashley M ^a   Mikolajczak, Sebastian A ^a   Wilson, Elizabeth M ^b   Grompe, Markus ^c   Kaushansky, Alexis ^a   Camargo, Nelly ^a   Bial, John ^b   Ploss, Alexander ^d   Kappe, Stefan H I ^a,e  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b Yecuris Corporation   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPORTED PROTEIN 2; FUMARYLACETOACETASE; MEMBRANE PROTEIN; PTEX 150; TRANSLOCON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPROMISED PATIENT; IN VIVO STUDY; LIVER CELL; MALARIA FALCIPARUM; MALARIA LIVER STAGE; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCHIZONT;

ANIMALS; ANOPHELES; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; HYDROLASES; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LIFE CYCLE STAGES; LIVER; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; PARASITEMIA; PARASITOLOGY; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TRANSPLANTATION CHIMERA;

EID: 84867154422     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62684     Document Type: Article

References (48)

1. WHO. World Malaria Report 2010. Geneva, Switzerland: World Health Organization; 2010.
2. Yamauchi LM, Coppi A, Snounou G, Sinnis P. Plasmodium sporozoites trickle out of the injection site. Cell Microbiol. 2007;9(5):1215-1222.
3. Mota MM, et al. Migration of Plasmodium sporozoites through cells before infection. Science. 2001;291(5501):141-144. (Pubitemid 32056684)
4. Vaughan AM, Aly AS, Kappe SH. Malaria parasite pre-erythrocytic stage infection: gliding and hiding. Cell Host Microbe. 2008;4(3):209-218.
5. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193(4254):673-675.
6. Mazier D, et al. Complete development of hepatic stages of Plasmodium falciparum in vitro. Science. 1985;227(4685):440-442. (Pubitemid 15153505)
7. Sattabongkot J, et al. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg. 2006;74(5):708-715. (Pubitemid 46774383)
8. Lindner SE, Miller JL, Kappe SH. Malaria parasite pre-erythrocytic infection: preparation meets opportunity. Cell Microbiol. 2012;14(3):316-324.
9. Tarun AS, et al. Quantitative isolation and in vivo imaging of malaria parasite liver stages. Int J Parasitol. 2006;36(12):1283-1293. (Pubitemid 44353485)
10. Tarun AS, et al. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci U S A. 2008;105(1):305-310.
11. Pei Y, et al. Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection. Mol Microbiol. 2010;75(4):957-971.
12. Vaughan AM, et al. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol. 2009;11(3):506-520.
13. Mikolajczak SA, et al. Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites. Cell Microbiol. 2011;13(8):1250-1260.
14. Mackellar DC, O'Neill MT, Aly AS, Sacci JB, JrCowman AF, Kappe SH. Plasmodium falciparum PF10-0164 (ETRAMP10.3) is an essential parasitophorous vacuole and exported protein in blood stages. Eukaryot Cell. 2010;9(5):784-794.
15. Morosan S, et al. Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J Infect Dis. 2006;193(7):996-1004.
16. Sacci JB, et al. Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int J Parasitol. 2006;36(3):353-360.
17. Meuleman P, et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology. 2005;41(4):847-856. (Pubitemid 40462948)
18. Mercer DF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med. 2001;7(8):927-933. (Pubitemid 32756430)
19. VanBuskirk KM, et al. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A. 2009;106(31):13004-13009.
20. Heckel JL, Sandgren EP, Degen JL, Palmiter RD, Brinster RL. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell. 1990;62(3):447-456.
21. Legrand N, et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe. 2009;6(1):5-9.
22. -/- mice. Nat Biotechnol. 2007;25(8):903-910.
23. Bissig KD, Le TT, Woods NB, Verma IM. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A. 2007;104(51):20507-20511.
24. Grompe M, et al. Pharmacological correction of neonatal lethal hepatic dysfunction in a murinemodel of hereditary tyrosinaemia type I. Nat Genet. 1995;10(4):453-460.
25. Bissig KD, et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest. 2010;120(3):924-930.
26. Fischer K, et al. Characterization and cloning of the gene encoding the vacuolar membrane protein EXP-2 from Plasmodium falciparum. Mol Biochem Parasitol. 1998;92(1):47-57.
27. Johnson D, et al. Characterization of membrane proteins exported from Plasmodium falciparum into the host erythrocyte. Parasitology. 1994;109(pt 1):1-9.
28. de Koning-Ward TF, et al. A newly discovered protein export machine in malaria parasites. Nature. 2009;459(7249):945-949.
29. Baer K, Klotz C, Kappe SH, Schnieder T, Frevert U. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog. 2007;3(11):e171.
30. Sturm A, et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science. 2006;313(5791):1287-1290. (Pubitemid 44330952)
31. Graewe S, et al. Hostile takeover by Plasmodium: reorganization of parasite and host cell membranes during liver stage egress. PLoS Pathog. 2011;7(9):e1002224.
32. Talman AM, Blagborough AM, Sinden RE. A Plasmodium falciparum strain expressing GFP throughout the parasite's life-cycle. PLoS One. 2010;5(2):e9156.
33. Takenaka K, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007;8(12):1313-1323. (Pubitemid 350138972)
34. Hu Z, Van Rooijen N, Yang YG. Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood. 2011;118(22):5938-5946.
35. Ranford-Cartwright LC, Mwangi JM. Analysis of malaria parasite phenotypes using experimental genetic crosses of Plasmodium falciparum. Int J Parasitol. 2012;42(6):529-534.
36. Jimenez-Diaz MB, et al. Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NODscid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrob Agents Chemother. 2009;53(10):4533-4536.
37. Arnold L, et al. Further improvements of the P. falciparum humanized mouse model. PLoS One. 2011;6(3):e18045.
38. Singh AP, et al. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell. 2007;131(3):492-504. (Pubitemid 350007696)
39. Karnasuta C, et al. Complete development of the liver stage of Plasmodium falciparum in a human hepatoma cell line. Am J Trop Med Hyg. 1995;53(6):607-611. (Pubitemid 26036347)
40. Meis JF, et al. Fine structure of the malaria parasite Plasmodium falciparum in human hepatocytes in vitro. Cell Tissue Res. 1986;244(2):345-350. (Pubitemid 16053385)
41. Jeffery GM, Wolcott GB, Young MD, Williams D. Exo-erythrocytic stages of Plasmodium falciparum. Am J Trop Med Hyg. 1952;1(6):917-925.
42. Shortt HE, Fairley NH, Covell G, Shute PG, Garnham PC. The pre-erythrocytic stage of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1951;44(4):405-419.
43. Meis JF, et al. Plasmodium falciparum: studies on mature exoerythrocytic forms in the liver of the chimpanzee, Pan troglodytes. Exp Parasitol. 1990;70(1):1-11. (Pubitemid 20061108)
44. Dembele L, et al. Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One. 2011;6(3):e18162.
45. Vaughan AM, Wang R, Kappe SH. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum Vaccin. 2010;6(1):107-113.
46. Wang R, Smith JD, Kappe SH. Advances and challenges in malaria vaccine development. Expert Rev Mol Med. 2009;11:e39.
47. Khan SM, Janse CJ, Kappe SH, Mikolajczak SA. Genetic engineering of attenuated malaria parasites for vaccination [published online ahead of print May 3, 2012]. Curr Opin Biotechnol. doi:10.1016/j.copbio.2012.04.003.
48. Labaied M, Harupa A, Dumpit RF, Coppens I, Mikolajczak SA, Kappe SH. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect Immun. 2007;75(8):3758-3768. (Pubitemid 47206273)